Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.32 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.31 |
| ▸ | PPARA | Q07869 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22628715 | 0.92 | S1PR1 (0.34) | CA2NR1H4S1PR1PPARA | |
| SCHEMBL22628832 | 0.87 | S1PR1 (0.30) | CA2S1PR1PPARA | |
| SCHEMBL21735637 | 0.86 | NR1H4 (0.31) | CA2NR1H4S1PR1 | |
| SCHEMBL21735531 | 0.86 | FGFR1 (0.32) | CA2NR1H4S1PR1 | |
| SCHEMBL21735763 | 0.86 | CA2 (0.32) | CA2NR1H4S1PR1 | |
| SCHEMBL22630012 | 0.83 | CA2 (0.31) | CA2 | |
| SCHEMBL22630007 | 0.82 | CA2 (0.32) | CA2 | |
| SCHEMBL22629862 | 0.80 | S1PR1 (0.34) | CA2NR1H4S1PR1PPARA | |
| SCHEMBL22630112 | 0.79 | NR1H4 (0.31) | NR1H4 | |
| SCHEMBL21734980 | 0.75 | S1PR1 (0.31) | CA2S1PR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11014901-B2 | Hydrophobic compounds for optically active devices | MERCK PATENT GMBH (DE) | 2021-05-25 | — | — | US | disclosed |
| US-20200055833-A1 | HYDROPHOBIC COMPOUNDS FOR OPTICALLY ACTIVE DEVICES | MERCK PATENT GMBH (DE) | 2020-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200055833-A1 | HYDROPHOBIC COMPOUNDS FOR OPTICALLY ACTIVE DEVICES | UACA, CRYZ, TRPA1 | CA2 3899/4885NR1H4 898/4885S1PR1 3951/4885 |
| US-11014901-B2 | Hydrophobic compounds for optically active devices | UACA, CRYZ, TRPA1 | CA2 3899/4885NR1H4 898/4885S1PR1 3951/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.